U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07700433) titled 'Safety and Efficacy of the BTL-043 and BTL-899 Devices in Alleviating Back Pain' on July 09.
Brief Summary: The study will evaluate the clinical efficacy and performance of the BTL-043 and BTL-899 devices for alleviating back pain. It is a prospective, multi-center, open-label, single-arm study. Subjects will be required to complete four (4) treatment visits and two (2) follow-up visits. At the baseline visit, the Oswestry Disability Index (ODI), Visual Analogue Scale for pain (VAS), the Quebec Back Pain Disability Index (QBPDS), palpation of the treatment area, Fingertip-to-Floor-Flexion (FTFF) test, and Lateral FTFF test will be p...